4//SEC Filing
Moxham Christopher 4
Accession 0000899243-21-005666
CIK 0001680581other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:30 PM ET
Size
5.4 KB
Accession
0000899243-21-005666
Insider Transaction Report
Form 4
Moxham Christopher
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-08+100,000→ 100,000 totalExercise: $12.60Exp: 2031-02-07→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 8, 2021 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of February 6, 2021, subject to continued service.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001843784
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:30 PM ET
- Size
- 5.4 KB